MedTrace Logo

DCE-MRI and DWI for Detection and Diagnosis of Breast Cancer

NCT02022579 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2018-10-11

No results posted yet for this study

Summary

A type of magnetic resonance imaging called diffusion weighted imaging (DWI) will be tested to define cancerous from non-cancerous lesions in the breast.

Conditions

Interventions

PROCEDURE

DCE-MRI and DWI

DCE-MRI defined lesion(s) compared with biopsy results or 1-year follow up

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • Eastern Cooperative Oncology Group

    collaborator NETWORK

  • American College of Radiology Imaging Network

    lead NETWORK

Principal Investigators

  • Savannah Partridge, PhD · University of Washington

  • Habib Rahbar, MD · University of Washington

  • Thomas Chenevert, PhD · University of Michigan

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-01-31
Primary Completion
2018-11-30
Completion
2019-03-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02022579 on ClinicalTrials.gov